Your browser doesn't support javascript.
loading
Exploring Innovative Leishmaniasis Treatment: Drug Targets from Pre-Clinical to Clinical Findings.
Santana, Wanessa; de Oliveira, Simone S C; Ramos, Mariana H; Santos, André L S; Dolabella, Silvio S; Souto, Eliana B; Severino, Patrícia; Jain, Sona.
Affiliation
  • Santana W; Post-Graduation Program in Industrial Biotechnology, University of Tiradentes, Aracaju, Sergipe, Brazil.
  • de Oliveira SSC; Institute of Microbiology Paulo de Góes, Department of General Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Ramos MH; Post-Graduation Program in Industrial Biotechnology, University of Tiradentes, Aracaju, Sergipe, Brazil.
  • Santos ALS; Institute of Microbiology Paulo de Góes, Department of General Microbiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Dolabella SS; Laboratory of Entomology and Tropical Parasitology, Department of Morphology, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil.
  • Souto EB; Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, Coimbra, Portugal.
  • Severino P; CEB - Center of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
  • Jain S; Post-Graduation Program in Industrial Biotechnology, University of Tiradentes, Aracaju, Sergipe, Brazil.
Chem Biodivers ; 18(9): e2100336, 2021 Sep.
Article in En | MEDLINE | ID: mdl-34369662

Full text: 1 Database: MEDLINE Main subject: Leishmaniasis, Cutaneous / Leishmania / Leishmaniasis, Visceral / Antiprotozoal Agents Type of study: Diagnostic_studies Limits: Humans Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Leishmaniasis, Cutaneous / Leishmania / Leishmaniasis, Visceral / Antiprotozoal Agents Type of study: Diagnostic_studies Limits: Humans Language: En Year: 2021 Type: Article